Raajit K. Rampal, MD, PhD
Leukemia Specialist
My Role at MSKWe post reviews for MSK healthcare providers who have at least 30 patient experience surveys completed. If you do not see reviews for a provider, it may be because they do not yet have enough survey responses, or the provider may not be part of the group of healthcare providers included in the survey.
Only outpatient providers are included in the survey. Healthcare providers who only work in the hospital or in urgent care are not included in the survey. Pathologists or researchers who do not provide direct care to patients do not have reviews.
Areas of Expertise
My Specialties
- Myeloproliferative Neoplasms
- Acute and Chronic Leukemia
- Myelodysplastic Syndrome
About Me
- Director, Center for Hematologic Malignancies
- Director, Myeloproliferative Neoplasms Program
I am a hematologist-oncologist who specializes in the treatment of myeloproliferative neoplasms (MPN) and leukemia. I am dedicated to providing my patients with the best possible care, taking into account the individual needs of each patient and his or her family.
Read more
In addition, I am an active researcher whose focus is the development of new and innovative approaches to treating MPNs and leukemia. I am working to understand the genetic events that contribute to the development and progression of leukemia and MPNs in the hope of developing new targeted therapies for people with these diseases. I also work on developing and running novel clinical trials with molecularly targeted agents for patients with MPNs and leukemia. Through these efforts, I am committed to improving outcomes for people with these disease
A leukemia specialist is a doctor with special training in diagnosing and treating leukemia.
My Specialties
- Myeloproliferative Neoplasms
- Acute and Chronic Leukemia
- Myelodysplastic Syndrome
Education
- MD, Stony Brook University
Residencies
- Internal Medicine - University of Chicago Hospitals
Fellowships
- Hematology/Oncology - Memorial Sloan Kettering Cancer Center
- Medicine - Weill Cornell Medical College
Board Certifications
- Internal Medicine
- Medical Oncology
- Hematology
Insurance Information
Understanding your insurance options is an important part of managing your cancer care. We have relationships with many common healthcare providers and plans.
In Network Coverage Type
PPO, POS, EPO, HMO
In Network Coverage Type
PPO, HMO, DSN
In Network Coverage Type
HMO, PPO
In Network Coverage Type
HMO, EPO PPO, POS
In Network Coverage Type
PPO, POS, EPO, HMO
Offers a qualified health plan from the Health Insurance Marketplace. Call Emblem to learn more.
In Network Coverage Type
PPO, HMO
In Network Coverage Type
PPO
In Network Coverage Type
HMO, EPO
Offers a qualified health plan from the Health Insurance Marketplace. Call Fidelis to learn more.
In Network Coverage Type
EPO, HMO, PPO, POS
Offers a qualified health plan from the Health Insurance Marketplace. Call Healthfirst to learn more.
In Network Coverage Type
HMO
In Network Coverage Type
PPO
In Network Coverage Type
EPO
In Network Coverage Type
EPO
In Network Coverage Type
Federal Government
In Network Coverage Type
PPO, POS, EPO, HMO
In Network Coverage Type
State Government
Don't see your carrier or plan? We can help you understand your coverage.
If you don't have health insurance or are worried that your care may not be fully covered, our financial assistance programs may be able to help.
If you have questions about insurance, call us at 646-497-9176.
Make an Appointment
Contact and Location
Dr. Rampal sees patients at one location.
Looking to see a doctor at a different location? See all MSK locations.
Colleagues
Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.
Clinical Trials
- Clinical Trials Investigated by Dr. Rampal
- A Phase 1 Study of INCA033989 in People With Myeloproliferative Neoplasms
- A Phase 1 Study of JNJ-88549968 in People With Myeloproliferative Neoplasms
- A Phase 1 Study of Ruxolitinib plus Abemaciclib to Treat Myelofibrosis
- A Phase 1/3 Study to Assess Selinexor Plus Ruxolitinib in People with Untreated Myelofibrosis
Read more
- Clinical Trials Co-Investigated by Dr. Rampal
- A Phase 1b/2a Study of DISC-0974 in People With Myelofibrosis and Anemia
- A Phase I Study of TP-3654 in People with Myelofibrosis
Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.
You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.
Search clinical trialsResearch and Publications
Visit PubMed for a full listing of Dr. Rampal’s journal articles. Pubmed is an online index of research papers and other articles from the US National Library of Medicine and the National Institutes of Health.
See all on PubMedPatient Reviews
Your trust is our main concern
We strive to keep reviews trustworthy, honest and fair. Learn more about our patient experience reviews.
Disclosures
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Raajit K. Rampal discloses the following relationships and financial interests:
-
AbbVie
Professional Services and Activities -
American Society of Hematology
Professional Services and Activities -
Boxer Capital, LLC
Professional Services and Activities -
Chinese Academy of Medical Sciences
Professional Services and Activities -
Cogent Biosciences, Inc.
Professional Services and Activities -
CTI BioPharma Corp.
Professional Services and Activities -
GlaxoSmithKline
Professional Services and Activities -
Incyte
Professional Services and Activities
-
Jubilant Therapeutics Inc.
Professional Services and Activities -
MorphoSys AG
Professional Services and Activities -
MPN Research Foundation
Professional Services and Activities -
Noble Insights
Professional Services and Activities -
PharmaEssentia
Professional Services and Activities -
Protagonist Therapeutics, Inc.
Professional Services and Activities -
Sumitomo Pharma
Professional Services and Activities
If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.
The information published here is a complement to other publicly reported data and is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2023 through disclosure submission in spring 2024). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].